Senior insider sale
Chief Executive Officer at ARROWHEAD PHARMACEUTICALS, INC. — senior position signals high conviction
$19.56M
295.33K shares
What this filing means
ANZALONE CHRISTOPHER RICHARD plans to sell 295.33K shares of ARROWHEAD PHARMACEUTICALS, INC. valued at approximately $19.56M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/22/2025ACC: 0001628280-25-058500
DirectorOfficer· Chief Executive Officer
Since Aug 2018
295.33K
Shares to sell
$19.56M
Approx. market value
93.61K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Compensation
Compensation
12/20/2022
93.61KTotal acquired93.61K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/20/2022 | Compensation Compensation | 93.61K | — |
| Total | 93.61K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
13.45K
Market value
$909.6K
12/19/2025
—Completed
Units to sell
85K
Market value
$5.44M
12/17/2025
—Completed
Units to sell
54.30K
Market value
$3.40M
12/16/2025
—Completed
Units to sell
130K
Market value
$8.95M
12/15/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
12.59K
Market value
$861.3K
12/22/2025
Total
Units
295.33K
Value
$19.56M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/19/2025 | 13.45K | $909.6K | — | Completed |
12/17/2025 | 85K | $5.44M | — | Completed |
12/16/2025 | 54.30K | $3.40M | — | Completed |
12/15/2025 | 130K | $8.95M | — | Completed |
| Planned — Approximate Date | ||||
12/22/2025 | 12.59K | $861.3K | NASDAQ | Planned |
| Total | 295.33K | $19.56M | ||